{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:09:33Z","timestamp":1761707373356},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1006\/gyno.2000.5740","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T18:50:18Z","timestamp":1032288618000},"page":"319-320","source":"Crossref","is-referenced-by-count":50,"title":["Germline BRCA2 Mutation in a Patient with Fallopian Tube Carcinoma: A Case Report"],"prefix":"10.1006","volume":"77","author":[{"given":"Peter G.","family":"Rose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Shrigley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia L.","family":"Wiesner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.2000.5740_RF1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00006254-196104000-00022","article-title":"Primary carcinoma of the fallopian tube","volume":"16","author":"Sedlis","year":"1961","journal-title":"Obstet Gynecol Surv"},{"key":"10.1006\/gyno.2000.5740_RF2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/gyno.1996.4519","article-title":"Early occurrence and prognostic significance of p53 alteration in primary carcinoma of the fallopian tube","volume":"64","author":"Zheng","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2000.5740_RF3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/BF00223867","article-title":"Linkage analysis of 25 Canadian breast and breast\u2013ovarian cancer families","volume":"95","author":"Tonin","year":"1995","journal-title":"Hum Genet"},{"key":"10.1006\/gyno.2000.5740_RF4","first-page":"976","article-title":"BRCA1 gene mutations in sporadic ovarian carcinomas: detection by PCR and reverse transcriptase allele-specific oligonucleotide hybridization","volume":"45","author":"Tong","year":"1999","journal-title":"Clin Chem"},{"key":"10.1006\/gyno.2000.5740_RF5","first-page":"1031","article-title":"BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2","volume":"60","author":"Schubert","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1006\/gyno.2000.5740_RF6","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z","article-title":"The genetic attributable risk of breast and ovarian cancer","volume":"77","author":"Claus","year":"1996","journal-title":"Cancer"},{"key":"10.1006\/gyno.2000.5740_RF7","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","article-title":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews","volume":"336","author":"Struewing","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1006\/gyno.2000.5740_RF8","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","article-title":"Risks of cancer in BRCA1-mutation carriers","volume":"343","author":"Ford","year":"1994","journal-title":"Lancet"},{"key":"10.1006\/gyno.2000.5740_RF9","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","volume":"91","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1006\/gyno.2000.5740_RF10","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0029-7844(98)00223-3","article-title":"BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum","volume":"92","author":"Bandera","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1006\/gyno.2000.5740_RF11","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1200\/JCO.1996.14.5.1730","volume":"14","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.2000.5740_RF12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/ng1096-185","article-title":"Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2","volume":"14","author":"Roa","year":"1996","journal-title":"Nat Genet"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825800957408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825800957408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T22:26:23Z","timestamp":1557354383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825800957408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["S0090825800957408"],"URL":"https:\/\/doi.org\/10.1006\/gyno.2000.5740","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}